Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rubenstein

Showing results (241-250 of 477) with videos related to

Pageof 48
Sort By:
Diabetes|August 1, 1985
Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapyR M Bergenstal, J Dupre, P M Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like materialK H Gabbay, R M Bergenstal, J Wolff, et al.
Diabetes|May 1, 1983
Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pumpR M Bergenstal, K S Polonsky, G Pons, et al.
Nature|November 27, 1975
Syntheses and immunological evaluation of bovine proinsulin C-peptide analoguesN Yanaihara, N Sakura, C Yanaihara, et al.
Diabetes|January 1, 1978
C-peptide in conditions other than diabetes mellitusD L Horwitz, A H Rubenstein, M E Mako, et al.
The Journal of Clinical Investigation|May 1, 1984
Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog modelS E Shoelson, K S Polonsky, A Zeidler, et al.
The New England Journal of Medicine|April 22, 1976
Familial hyperproinsulinemia. An autosomal dominant defectK H Gabbay, K DeLuca, J N Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1976
Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetesS F Kuku, A Zeidler, D S Emmanouel, et al.
Journal of Biomedical Materials Research|March 1, 1980
Design of an artificial skin. II. Control of chemical compositionI V Yannas, J F Burke, P L Gordon, et al.
Biochemical and Biophysical Research Communications|February 12, 1981
Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulinS C Kwok, S J Chan, A H Rubenstein, et al.
Pageof 48

Showing results (241-250 of 477) with videos related to

Sort By:
Pageof 48
Diabetes|August 1, 1985
Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapyR M Bergenstal, J Dupre, P M Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like materialK H Gabbay, R M Bergenstal, J Wolff, et al.
Diabetes|May 1, 1983
Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pumpR M Bergenstal, K S Polonsky, G Pons, et al.
Nature|November 27, 1975
Syntheses and immunological evaluation of bovine proinsulin C-peptide analoguesN Yanaihara, N Sakura, C Yanaihara, et al.
Diabetes|January 1, 1978
C-peptide in conditions other than diabetes mellitusD L Horwitz, A H Rubenstein, M E Mako, et al.
The Journal of Clinical Investigation|May 1, 1984
Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog modelS E Shoelson, K S Polonsky, A Zeidler, et al.
The New England Journal of Medicine|April 22, 1976
Familial hyperproinsulinemia. An autosomal dominant defectK H Gabbay, K DeLuca, J N Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1976
Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetesS F Kuku, A Zeidler, D S Emmanouel, et al.
Journal of Biomedical Materials Research|March 1, 1980
Design of an artificial skin. II. Control of chemical compositionI V Yannas, J F Burke, P L Gordon, et al.
Biochemical and Biophysical Research Communications|February 12, 1981
Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulinS C Kwok, S J Chan, A H Rubenstein, et al.
Pageof 48